Physician profile
Mark E Leo
NPI 1730117730
$12,546.98
in general payments reported to CMS, 2019-2025
34 companies · $7,435 in 2025
The $7,435 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.16 · 2021: $97.80 · 2022: $1,046 · 2023: $2,749 · 2024: $1,207 · 2025: $7,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,857 · Travel and Lodging: $3,434 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,856.50 |
| Travel and Lodging | $3,433.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avyxa Pharma, LLC | $3,950.87 | 2025 | |
| Teleflex LLC | $2,014.57 | 2022-2025 | Urolift, Barrigel |
| Coloplast Corp | $1,398.40 | 2021-2025 | Self-Cath |
| Procept Biorobotics Corporation | $1,030.97 | 2023-2025 | Aquabeam Robotic System |
| Valencia Technologies Corporation | $1,021.10 | 2022-2025 | Ecoin Device Kit |
| Boston Scientific Corporation | $426.34 | 2023-2025 | Ams 700, Spaceoar Vue System - 10ml, Axonics |
| Janssen Biotech, INC. | $327.08 | 2024-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $277.04 | 2022-2025 | Prolaris |
| Janssen Scientific Affairs, LLC | $227.46 | 2025 | Erleada, Balversa, Akeega |
| Axonics, INC. | $225.39 | 2022-2024 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $197.83 | 2020-2024 | Xiaflex, Aveed, Edex |
| Immunitybio, INC. | $168.24 | 2025 | |
| Tolmar, INC. | $161.76 | 2023-2025 | Eligard |
| Antares Pharma, INC. | $155.79 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Laborie Medical Technologies Corp. | $153.68 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $135.90 | 2024-2025 | Xiaflex, Aveed, Edex |
| Abbvie INC. | $99.85 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $85.44 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $74.42 | 2025 | Adstiladrin |
| Bluewind Medical | $54.86 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $49.46 | 2025 | |
| Dendreon Pharmaceuticals LLC | $46.30 | 2025 | Provenge |
| Pfizer INC. | $41.25 | 2023 | |
| Blue Earth Diagnostics | $29.96 | 2025 | Posluma |
| Storz Medical America, INC. | $27.58 | 2025 | |
| Mission Pharmacal Company | $26.03 | 2023 | Uribel |
| Bioprotect Medical, INC. | $25.46 | 2025 | Bioprotect Balloon Implant System |
| Calyxo, INC. | $18.50 | 2025 | Cvac Aspiration System |
| Urovant Sciences INC | $18.36 | 2022 | |
| Myovant Sciences INC. | $18.00 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.79 | 2022 | |
| Allergan, INC. | $15.02 | 2021 | |
| Dentsply Ih Ab | $14.12 | 2023 | Lofric |
| Angiodynamics, INC. | $13.16 | 2024 | Nanoknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Leo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.